Yong‐Mi Kim

This study identifies mitochondrial transfer from M2-like macrophages to AML cells as a mechanism of chemoresistance, showing that LIMK inhibition and metformin block this transfer and restore chemosensitivity.

This paper introduces a novel targeted nanoparticle platform for cancer therapy, showing significant tumor reduction and complete ablation in preclinical models.

This paper identifies UNC7040 as a potent CBX8-specific positive allosteric modulator that disrupts PRC1 function and reduces cancer cell proliferation.